Mozz, they may get some people excited in the compound and what it can do for sufferers, but these funds will have some business questions as well.
Like those pertinent Q's that were asked and dodged / ignored a few weeks back?
What is your current cash position? = "Well we started the FY with A$72m" (not really a current statistic)
What have you modelled for cash burn going fwd as you start the trials? = "Given it is a multi site, multi currency program, it will be some time until we get a true handle on what that spend will look like" (timestamp 71mins into webinar video).... Sure, but you must have modelled something right?
Ok, maybe we try to reverse engineer this, what have you modelled as a cost per patient? Is it the median cost of circa US$40k that anyone can google??
How many patients in all the studies across the 76 sites (US, Eur & Aus)?
If we do a range of 1,000 to 1,500 patients x $40k, would that be reasonable? Do you have US$40m - US$60m set aside for this?
Have your 2b results been peer reviewed?
Mozz, I believe you are spot on, with your longer term (5yr +) beliefs in the product, it is the short term uncertainty on the business / financials side that concerns me.
- Forums
- ASX - By Stock
- PAR
- PAR General discussion
PAR General discussion, page-195
-
- There are more pages in this discussion • 145 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.0¢ |
Change
-0.015(6.98%) |
Mkt cap ! $70.04M |
Open | High | Low | Value | Volume |
21.0¢ | 21.0¢ | 20.0¢ | $201.6K | 994.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 429247 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.0¢ | 13806 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 389247 | 0.200 |
8 | 133607 | 0.195 |
17 | 238789 | 0.190 |
4 | 92160 | 0.185 |
8 | 122773 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.210 | 13806 | 2 |
0.215 | 28509 | 1 |
0.220 | 59615 | 6 |
0.225 | 28604 | 2 |
0.230 | 16334 | 2 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
PAR (ASX) Chart |